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a b s t r a c t
Aptamers are promising gene components that can be used for the construction of synthetic gene
circuits. In this study, we isolated an RNA aptamer that speciﬁcally inhibits transcription of T7 RNA
polymerase (RNAP). The 38-nucleotide aptamer, which was a shortened variant of an initial SELEX
isolate, showed moderate inhibitory activity. By stepwise doped-SELEX, we isolated evolved variants
with strong inhibitory activity. A 29-nucleotide variant of a doped-SELEX isolate showed 50% inhibitory
concentration at 11 nMunder typical in vitro transcription conditions. Pull-down experiments revealed
that the aptamer inhibited the association of T7 RNAP with T7 promoter DNA.
c© 2012 Federation of European Biochemical Societies. Published by Elsevier B.V.
Open access under CC BY-NC-ND license.1. Introduction
Synthetic gene circuits have applications in the manipulation of
biological systems aswell as in the generation of simpliﬁedmodels for
certain biological phenomena [1–3]. These circuits are constructed by
assembling natural, engineered, and/or de novo generated gene com-
ponents. Because synthetic gene circuits have great potential not only
for basic biological studies but for industrial andmedical applications,
efforts are being made to design novel circuit types [1–3].
In nature, RNAs play a wide variety of dynamic roles in intra-
cellular events [4]. These knowledge accumulations have inspired
the engineering of artiﬁcial gene components based on functional
RNAs [5–7]. Compared with proteins, functional RNAs have several
attractive features. For example, guide RNAs, including antisense and
short interference RNAs, can be designed simply based on base-pair
formations. Concerning structural RNAs, the modular properties and
the predictability of their two-dimensional (2D) architecture have al-
lowed for rational engineering of these molecules. Furthermore, it is
also possible to generate novel, artiﬁcial RNAs with desired binding
or catalytic properties by employing an in vitromethodology [8,9].
RNA aptamers are artiﬁcial RNAs that are selected in vitro from
large random sequence libraries on the basis of their high afﬁnity to
target molecules by a process known as SELEX (Systematic Evolution
of Ligands by EXponential enrichment) [10–14]. Since the establish-
ment of this procedure, a wide variety of aptamers has been gener-
ated, and their applications have been extensively studied [12–14].
In this study, we isolated an inhibitory RNA aptamer against T7Abbreviations: RNAP, RNA polymerase; SELEX, systematic evolution of ligands by
exponential enrichment
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wise doped-SELEX, a small aptamer with strong inhibitory activity
was developed. Because T7 RNAP is the most commonly used en-
zyme for in vitro transcription [15–17] and is employable for in vivo
expression [18–20], the aptamer might be a promising gene compo-
nent for the construction of synthetic gene circuits.ss u2. Materials and methods
2.1. SELEX
Preparation of recombinant hexa-histidine-tagged RNAPs and SE-
LEX against T7 RNAP were performed as previously described [21].
The following synthetic DNA was used as an initial DNA pool for
SELEX; 5′-AATTTAGGTG ACACTATAGG ATGGCAGCGG AGAG-N35-
CAGCCCACAC CACTCTCC-3′ (SP6 promoter sequence is underlined,
and N35 represents 35-nucleotides [nts] of random sequence). Oth-
erwise mentioned, all synthetic DNAs were purchased from Operon
Biotechnologies (Japan).
For the ﬁrst doped-SELEX, the following synthetic DNA (purchased
fromGeneDesign Inc., Japan)was employed as an initial DNApool; 5′-
AATTTAGGTG ACACTATAGC CCCAGGGATG GGGGAGAGAT ATAGtg-
tagt gtaagtcaat tctactttcg ttgcagccca cACCACTCGGCATCCGTGCCGAG-
3′ (Uppercase and underlined letters indicate primer-binding sites
and SP6 promoter sequence, respectively. Positions indicated by low-
ercase letterswere 15%-doped, that is,mixture of 85% of a base identi-
cal to that of the parental T06-38 sequence and 3 × 5%of other bases.)
For the second doped-SELEX, the following synthetic DNA (purchased
from Gene Design Inc., Japan) was employed as an initial DNA pool;
5′-AATTTAGGTG ACACTATAGC CCCAGGGATG GGGCAAAAGt gtagtg-
TAAG TCAAtTCtAc tttCgTTGCa gcccacATTA CTCGGCATCCGTGCCGAG-
3′ (Uppercase and underlined letters indicate primer binding sitesnder CC BY-NC-ND license.
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Fig. 1. Estimation of dissociation constant (KD) by ﬁlter-binding assay. Two indepen-
dent duplicate experiments were performed. Error bars indicate standard deviation.
The primary sequences of the aptamers are shown in Table 1.
and SP6 promoter sequence, respectively. Positions indicated by low-
ercase letters were 60%-doped, that is, mixture of 40% of a base iden-
tical to that of the parental T06-38 sequence and 3 × 20% of other
bases). The detailed conditions of the doped-SELEX are described in
Supplemental Table 1.
2.2. Biochemical analyses of aptamers
Filter-binding and transcription inhibition assays were performed
as previously described [21].
For the evaluation of competition between T7 promoter DNA
and aptamer T230-29, 30 pmol of hexa-histidine-tagged T7 RNAP
was immobilized onto 3 μL of HisLink Protein Puriﬁcation Resin
(Promega). The resin was washed two times with buffer P (40 mM
Tris–HCl, pH 7.6, 6 mM MgCl2, 2 mM spermidine, 1 mM DTT, 0.01%
BSA, 0.05% NP-40) and re-suspend in 50 μL buffer P supplemented
with 2 units of RNase inhibitor (Takara Bio, Japan). Then, 50 μL of
buffer P containing 10 pmol double-stranded DNA of T7 promoter
sequence (Sequence of the non-template strandwas 5′-CAAATTAATA
CGACTCACTA TAGGGA-3′. The 5′-terminal of the non-template strand
was ﬂuorescently labeled with 6-carboxyﬂuorescein [6 -FAM].) and
indicated amount of the RNA was added. After 10 min incubation at
room temperature, the resinwaswashedoncewith 100μL of buffer P,
re-suspendedwith 50μL of TE buffer, followedbyphenol/chloroform
extraction. TenμL of thewater phasewas subjected to 10% PAGE, and
the recovered DNA was quantiﬁed by Storm 840 (GE Healthcare).
3. Results
3.1. Isolation of an inhibitory RNA aptamer against T7 RNAP
Recently, we succeeded in isolating an inhibitory RNA aptamer
against SP6 RNAP [21]. To generate an orthogonal pairing of RNAP
with an inhibitory aptamer, we intended to isolate inhibitory RNA
aptamers against T7 RNAP. SELEX was carried out against hexa-
histidine-tagged T7 RNAP using an initial pool containing 3 × 1014
variants of 71-nt RNA with 35-nt random sequences (hereafter, N35
RNA).
After 10 rounds of SELEX, the pool RNA showed increased afﬁn-
ity for and moderate inhibitory activity against T7 RNAP (data not
shown). The variants in the pool were cloned, and their inhibitory ac-
tivitieswere analyzed. Among 17 clones picked randomly, four clones
showed apparent inhibitory activity, and the strongest among these,
T06, was chosen for further analyses (Table 1).
Fig. 2. Estimation of inhibitory activity of the aptamers against T7 RNAP. In vitro tran-
scription by T7 RNAP was carried out using the indicated concentrations of template
DNA in the presence RNAs. (A) Transcription with 15 nM DNA in the presence of N35
RNA. (B) Transcription with 15 nM DNA in the presence of aptamer T06. (C) Transcrip-
tion with 150 nM DNA in the presence of aptamer T06. (D) Transcription with 15 nM
DNA in the presence of aptamer T06-38. (E) Transcription with 150 nM DNA in the
presence of aptamer T06-38. (F) Transcription with 150 nM DNA in the presence of
aptamer T230-29. The value under each lane of the gel images indicates the relative
amount of transcript compared with that of the same reaction in the absence of RNA.
Two independent duplicate experiments were performed, and the mean values are
shown.
The dissociation constant (KD) of aptamer T06 was 8.0 (±2.4) nM
as estimated by the ﬁlter-binding assay (Fig. 1). In contrast, negative
control RNAs [the initial pool RNA (N35 RNA) and a 68-nt RNA ap-
tamer (S05 RNA) against SP6 RNAP [21]] showed no apparent binding
to T7 RNAP in concentrations of up to 1 μM (Fig. 1). Under the in
vitro transcription conditions using a low concentration of template
DNA (15 nM), the 50% inhibitory concentration (IC50) value for the
aptamer was estimated to be 51.7 (±7.5) nM, whereas no inhibitory
activity was observed for the negative controls (Fig. 2A, 2B, and Table
2 [21]). The aptamer failed to inhibit SP6 RNAP (31% identical to T7
RNAP) even at concentrations of up to 4 μM, thus demonstrating its
speciﬁcity [21]. However, it is noteworthy that higher concentrations
of template DNA remarkably weakened the inhibitory activity of the
aptamer; in the presence of 150 nM DNA, the IC50 value increased to
282 (±60) nM (Fig. 2C and Table 2).
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Table 1
Primary sequences of RNA aptamers against T7 RNAP.
RNA Sequence (5′ to 3′) Length




T06 - 38b gUGUAGUGUA AGUCAAUUCU ACUUUCGUUG
CAGCCCAC
38-nts
T230 - 29 GCGUAAGUCA AUUCCACUAU CAUUGCUGC 29-nts
a The region covering the aptamer T06 - 38 sequence is underlined.
b The guanosine residue that was not mutagenized in the doped-SELEX pools is indicated by a lowercase letter. Residues completely conserved amongst the ﬁrst doped-SELEX
isolates are indicated in boldface.
Table 2
Inhibitory activities of RNA aptamers against T7 or SP6 RNAPs.
Aptamer T7 RNAP T7 RNAP SP6 RNAP
15 nM DNA 150 nM DNA 50 nM DNA
T06 51.7 (±7.5) nM 282 (±60) nM >10,000 nM
T06 - 38 111 (±29) nM 411 (±110) nM n.a.
T230 - 29 n.a. 11.2 (±3.7) nM n.a.
S05 >10,000 nM n.a. 24.8 (±6.7) nM
IC50 values for aptamers against T7 or SP6 RNAPs in the presence of the indicated
concentrations of template DNA are summarized. The data for aptamer S05 is from a
previous report [21].
To elucidate the essential elements of aptamer T06, we examined
deletions at the 5′- and 3′-ends and found that 23-nt and 10-nt dele-
tions from 5′- and 3′-terminals, respectively, only slightly affected its
activity. The resulting 38-nt variant aptamer T06-38 (Table 1) had a
KD value of 10.5 (±2.1) nM (Fig. 1). The IC50 values in the presence
of 15 nM and 150 nM template DNAwere estimated to be 111 (±29)
nM and 411 (±110) nM, respectively (Fig. 2D, 2E, and Table 2). Fur-
ther deletions from either 5′- or 3′-terminals drastically reduced the
inhibitory activity of the aptamer (data not shown).
3.2. Evolution of aptamer T06-38 by stepwise doped-SELEX
To obtain aptamers with higher inhibitory activity, in vitro evo-
lution of aptamer T06-38 was pursued by applying SELEX to an RNA
pool comprising 15% mutagenized variants of aptamer T06-38, or by
applying doped-SELEX [22]. The inhibitory activity of the pool RNA
was progressively increased, with the increase reaching a plateau af-
ter 4 rounds (data not shown). Among 74 clones randomly picked out
from the fourth round pool, 30 clones showed an activity comparable
to that of the parental aptamer (Supplemental Fig. 1). Unfortunately,
we failed to ﬁnd a highly improved aptamer from these clones. How-
ever, sequence comparisons revealed apparent sequence conserva-
tion among the active clones. In general, both 5′- and 3′-ends were
highly tolerant to base replacements, whereas the central regions
were less tolerant, and 16 residues were completely conserved (Sup-
plemental Fig. 1 and Table 1).
On the basis of these results, we developed a newly mutagenized
RNA pool. For this, 21 residues, not including the 16 residues found
to be completely conserved in the ﬁrst doped-SELEX isolates, were
60%mutagenized and again subjected to doped-SELEX. The inhibitory
activity of the pool RNAwas comparable with that of the parental ap-
tamer after 2 rounds, and exceeded it after 3 rounds (data not shown).
Among the 33 clones in the third round pool, 25 clones showed an
inhibitory activity that was at least comparable with the activity of
the parental aptamer (Supplemental Fig. 2). According to predictions
made using sequence alignment programs based on consensus 2D
structure (FoldalignM and MXSCARNA) [23,24], two base-pairing re-
gionswere found to be conserved among the inhibitory aptamers (Fig.
3AandSupplemental Fig. 2). Thesebase-pairingswere also foundcon-
served among the initial doped-SELEX isolates (Supplemental Fig. 1).
Fig. 3. Predicted 2D structures of the inhibitory aptamers against T7 RNAP. (A) Consen-
sus structures for aptamer T06-38 derivatives predicted by FoldalignM. Completely and
moderately conserved sequences are indicated by uppercase and lowercase letters, re-
spectively. Dots denote base-pairings. The conserved base-pairings identiﬁed through
sequence alignment by FoldalignM and MXSCARNA are highlighted with shadows. (B)
2D structure of aptamer T230-29.
Most isolates hadmutations at the 4th, 5th, 35th, and 36th nucleotide
positions (24, 22, 24, and 23 clones out of the 25 clones, respectively),
suggesting that the residues originally in place at these positionswere
unfavorable for the activity (discussed below).
Shortened variants, free from the primer-binding sites, were con-
structedbasedon the six aptamerswith the strongest inhibitory activ-
ity (T055, T230, T252, T253, T351, and T851). Among the six variants,
only the shortened T230 retained the full inhibitory activity (data not
shown), and thus, further truncations of aptamer T230 were exam-
ined. Through serial analyses of 5′- and 3′-deletions, the central 29-nt
sequence covering the conserved 2D structural motif was identiﬁed
as necessary and sufﬁcient for full inhibitory activity (Fig. 3B and Ta-
ble 1). The KD and IC50 in the presence of 150 nM DNA of this 29-mer
variant, T230-29,were estimated to be 2.9 (±0.9) nMand11.2 (±3.7)
nM, respectively (Fig. 1, 2F and Table 2).
3.3. Evaluation of the inhibitory mechanism of aptamer T230-29
The transcription inhibition assay described above showed that
the template DNA concentrations strongly affect the inhibitory activ-
ity of the aptamers (Fig. 2). Therefore, one might expect to ﬁnd that
DNA and aptamers compete with each other for binding to T7 RNAP,
with this competition being the basis of the inhibitory mechanism
by the aptamers. To conﬁrm this hypothesis, we performed a pull-
down experiment using resin-immobilized T7 RNAP (Fig. 4). In the
absence of RNA, T7 promoter DNA was found to be associated with
the immobilized T7 RNAP, and 15% of the DNA was recovered from
the resin (Fig. 4). In contrast, almost no associationwas observedwith
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Fig. 4. Evaluation of the inhibitory effect of aptamer T230-29 on T7 RNAP-T7 promoter
DNA association. The inhibitory effect of the aptamer on T7 RNAP-T7 promoter DNA
association was analyzed by pull-down assay employing resin-immobilized T7 RNAP.
Pull-down assays were performed in the presence of the indicated concentrations of
RNA. Lanes indicated by “Input” and “-RNAP” show 1/20 volume of the input DNA and
the result of the control experimentwithout the RNAP immobilization. The value under
each lane indicates the relative band intensity of the DNA compared with DNA recov-
ered in the absence of RNA. Two independent duplicate experiments were performed,
and the mean values are shown.
the control resin without the RNAP immobilization. When aptamer
T230-29 was simultaneously added with the DNA, the amount of the
recovered DNA reduced in a dose-dependent manner (Fig. 4). In con-
trast, DNA recoverywas rarely affected by the control RNA (N35RNA).
The results supported our hypothesis that DNA and aptamer compete
with each other in binding to T7 RNAP.
4. Discussion
In this study, we isolated an inhibitory RNA aptamer against T7
RNAP. By means of an in vitro evolution through stepwise doped-
SELEX, a 29-nt aptamer with strong inhibitory activity was success-
fully generated.
The doped-SELEX also revealed sequence/structure requirements
for activity (Fig. 3A). Although the conserved motif resided within
a central 29-nt region, and although this motif was sufﬁcient for
the full activity of one isolate (T230), the original isolate (T06) and
most of the examined isolates from the second doped-SELEX required
longer sequences in order to be active. One possible explanation for
this contradiction is that longer sequences are indispensable for the
maintenance of the active structures of these isolates. For example,
the expected active structure of aptamer T06-38 is unlikely to be the
most stable structure for the sequence (Supplemental Fig. 3) [25–27].
Short deletions from 5′- or 3′-ends are supposed to weaken the active
structure (Supplemental Fig. 3 A), whilst the inactive structure (Sup-
plemental Fig. 3 B) is likely to be less affected. This hypothesis also
explains why certain positions were highly replaced among the iso-
lates from the second doped-SELEX. The mutations at these hot spots
may stabilize active structures and/or destabilize inactive structures.
In the transcription inhibition assay, template DNA concentration
strongly affected the inhibitory activity of the aptamers (Fig. 2), and
the pull-down experiment showed that aptamer T230-29 inhibits
the association of T7 RNAP to T7 promoter DNA (Fig. 4). Although no
similarity was found between the aptamer and the T7 promoter, the
aptamer may bind directly to the promoter-recognition residues of
T7 RNAP in a manner similar to the promoter DNA. In contrast, the
inhibitory activity of the recently identiﬁed RNA aptamer against SP6
RNAP [21] is rarely affected by the DNA concentration (unpublished
observations), suggesting the involvement of a different inhibitory
mechanism in each case.
According to the proposed inhibitory mechanism, the aptamer
and T7 RNAP are expected to be of equal stoichiometry. Assuming
monophasic concentration dependence for the inhibitory effect, and
a Hill coefﬁcient of 1.0 in the transcription assay (Fig. 2), a non-
negligible amount of leaky transcription (∼10%) was predicted, even
in the presence of saturated concentrations of any of the analyzed
aptamers. Alternatively, the data can be interpreted assuming non-
monophasic behavior and/or lower values of the Hill coefﬁcient; for
instance, if higher aptamer concentrations were to induce autoinac-
tivation, for example, by undesired dimerization [28]. In either case,
the utility of these aptamers for efﬁcient transcription regulation is
restricted, and further efforts in molecular engineering and/or ex-
pression system design are required to overcome these limitations.
Previous studieshave shown that systemdesignmayaffordextremely
tight control of expression regulation employing repressor proteins
[29].
Because T7 and SP6 RNAPs can be employed as platforms for in
vivo gene expressions [18–20,30–33], aptamers speciﬁcally inhibiting
these RNAPs would be valuable gene components in the construction
of synthetic gene circuits. Several studies have shown that RNA ap-
tamers with afﬁnities similar to (or even lower than) those of the
aptamers against the RNAPs can efﬁciently inhibit their targets’ activ-
ities in vivo [34–38]. In addition, because of their high efﬁciency and
easiness of manipulation, the RNAPs are the most commonly used
enzymes for in vitro transcription [15–17, 39]. We expect that these
orthogonal pairings of RNAPs with the inhibitory aptamers will have
applications in the sophisticated design of translation-free, expres-
sion regulation systems [40–44].
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